Search filters

Filters
Clear All

Phase

  • 3
  • 22
  • 25
  • 19
  • 25
  • 2
  • 23

Found 25 dm-cardiology-waxman trials

A listing of dm-cardiology-waxman medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
99 years or below
All genders
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE. Up to 1200 subjects with intermediate-risk acute PE will be randomized. All subjects who sign informed consent and who meet all of the inclusion criteria and none …
99 years or below
All genders
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel group, event-driven, superiority, group sequential study to evaluate the efficacy and safety of milvexian in participants enrolled within 7 days of an Acute Coronary Syndrome. Participants will receive either milvexian/ placebo on a background of standard-of-care antiplatelet therapy. The total …
99 years or below
All genders
This is a prospective, multicenter,randomized, nonblinded study to evaluate the safety and effectiveness of the Aortix System versus standard of care medical therapy in patients hospitalized with ADHF and persistent congestion despite usual medical management and who are not being considered for nearterm advanced HF therapy (i.e., LVAD placement or …
99 years or below
All genders
The AMPLIFY EP Registry is an observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience with the TactiFlex Catheter Ablation system in the treatment of Atrial Fibrillation. Patient assessments will occur at pre- procedure and procedure, and 1 year post ablation.
99 years or below
All genders
The study is a prospective, open-label, multicenter, extension study of acoramidis in participants with newly diagnosed ATTR-CM (or both ATTR-CM and ATTR-PN). The study population will be participants from the AG10-501 study only who are newly diagnosed with ATTR-CM (or both ATTR-CM and ATTR-PN) during that study. Participants will be …
21 - 25 of 25